AAAAAA
Results:
1-16
|
Results: 16
Authors:
Yamato, K
Hashimoto, S
Imamura, T
Uchida, H
Okahashi, N
Koseki, T
Ishisaki, A
Kizaki, M
Miyazono, K
Ikeda, Y
Nishihara, T
Citation: K. Yamato et al., Activation of the p21(CIP1/WAF1) promoter by bone morphogenetic protein-2 in mouse B lineage cells, ONCOGENE, 20(32), 2001, pp. 4383-4392
Authors:
Muto, A
Kizaki, M
Kawamura, C
Matsushita, H
Fukuchi, Y
Umezawa, A
Yamada, T
Hata, J
Hozumi, N
Yamato, K
Ito, M
Ueyama, Y
Ikeda, Y
Citation: A. Muto et al., A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF, LEUKEMIA, 15(8), 2001, pp. 1176-1184
Authors:
Kizaki, M
Takayama, N
Kawai, Y
Okamoto, S
Ikeda, Y
Citation: M. Kizaki et al., Development of acute erythremia from myelodysplastic syndrome after treatment with 1,25-dihydroxyvitamin D-3, AM J HEMAT, 67(3), 2001, pp. 215-216
Authors:
Takayama, N
Kizaki, M
Hida, T
Kinjo, K
Ikeda, Y
Citation: N. Takayama et al., Novel mutation in the PML/RAR alpha chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoicacid in acute promyelocytic leukemia, EXP HEMATOL, 29(7), 2001, pp. 864-872
Authors:
Kobayashi, Y
Nakano, Y
Kizaki, M
Hoshikuma, K
Yokoo, Y
Kamiya, T
Citation: Y. Kobayashi et al., Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist, PLANTA MED, 67(7), 2001, pp. 628-633
Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia
Authors:
Matsushita, M
Ikeda, H
Kizaki, M
Okamoto, S
Ogasawara, M
Ikeda, Y
Kawakami, Y
Citation: M. Matsushita et al., Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia, BR J HAEM, 112(4), 2001, pp. 916-926
Authors:
Kinjo, K
Kizaki, M
Muto, A
Fukuchi, Y
Umezawa, A
Yamato, K
Nishihara, T
Hata, J
Ito, M
Ueyama, Y
Ikeda, Y
Citation: K. Kinjo et al., Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoicacid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice, LEUKEMIA, 14(3), 2000, pp. 431-438
Authors:
Yamato, K
Hashimoto, S
Okahashi, N
Ishisaki, A
Nonaka, K
Koseki, T
Kizaki, M
Ikeda, Y
Nishihara, T
Citation: K. Yamato et al., Dissociation of bone morphogenetic protein-mediated growth arrest and apoptosis of mouse B cells by HPV-16 E6/E7, EXP CELL RE, 257(1), 2000, pp. 198-205
Authors:
Kawamura, C
Kizaki, M
Yamato, K
Uchida, H
Fukuchi, Y
Hattori, Y
Koseki, T
Nishihara, T
Ikeda, Y
Citation: C. Kawamura et al., Bone morphogenetic protein-2 induces apoptosis in human myeloma cells withmodulation of STAT3, BLOOD, 96(6), 2000, pp. 2005-2011
Authors:
Kizaki, M
Fukuchi, Y
Ikeda, Y
Citation: M. Kizaki et al., A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo (review), INT J MOL M, 4(4), 1999, pp. 359-364
Authors:
Fukuchi, Y
Miyakawa, Y
Kizaki, M
Umezawa, A
Shimamura, K
Kobayashi, K
Kuramochi, T
Hata, J
Ikeda, Y
Tamaoki, N
Nomura, T
Ueyama, Y
Ito, M
Citation: Y. Fukuchi et al., Human acute myeloblastic leukemia-ascites model using the human GM-CSF- and IL-3-releasing transgenic SCID mice, ANN HEMATOL, 78(5), 1999, pp. 223-231
Authors:
Yoshinari, M
Imaizumi, M
Sato, A
Minegishi, M
Fujii, K
Suzuki, H
Miura, T
Funato, T
Saito, T
Chikaoka, S
Rikiishi, T
Kizaki, M
Iinuma, K
Citation: M. Yoshinari et al., G-CSF induces apoptosis of a human acute promyelocytic leukemia cell line,UF-1: Possible involvement of Stat3 activation and altered Bax expression, TOH J EX ME, 189(1), 1999, pp. 71-82
Authors:
Kinjo, K
Kizaki, M
Takayama, N
Michikawa, N
Oda, A
Okamoto, SI
Tahara, T
Kato, T
Miyazaki, H
Ikeda, Y
Citation: K. Kinjo et al., Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment, BR J HAEM, 105(2), 1999, pp. 382-387
Authors:
Matsushita, H
Kizaki, M
Kobayashi, H
Muto, A
Ikeda, Y
Citation: H. Matsushita et al., Induction of apoptosis in myeloid leukaemic cells by ribozymes targeted against AML1/MTG8, BR J CANC, 79(9-10), 1999, pp. 1325-1331
Authors:
Muto, A
Kizaki, M
Yamato, K
Kawai, Y
Kamata-Matsushita, M
Ueno, H
Ohguchi, M
Nishihara, T
Koeffler, HP
Ikeda, Y
Citation: A. Muto et al., 1,25-dihydroxyvitamin D-3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1), BLOOD, 93(7), 1999, pp. 2225-2233
Authors:
Kizaki, M
Muto, A
Kinjo, K
Ueno, H
Ikeda, Y
Citation: M. Kizaki et al., Application of heavy metal and cytokine for differentiation-inducing therapy in acute promyelocytic leukemia, J NAT CANC, 90(24), 1998, pp. 1906-1907
Risultati:
1-16
|